In prostate cancer, the expression of Cyclin A1 has been shown to be enhanced in metastatic lesions compared to the primary tumor, while its over-expression in stem-like cells fostered bone marrow homing and metastatic growth [16]. Here, CCNA1 is linked to prostate carcinoma.